Stay updated on Avelumab Program Rollover Study Clinical Trial
Sign up to get notified when there's something new on the Avelumab Program Rollover Study Clinical Trial page.

Latest updates to the Avelumab Program Rollover Study Clinical Trial page
- Check5 days agoChange DetectedNapoli, Italy was removed and Naples, Italy was added to the list of study locations. The update aligns the location naming with English usage for easier recognition.SummaryDifference0.0%

- Check12 days agoChange DetectedThe revision tag was updated to v3.5.0 and the previous tag v3.4.3 was removed.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing v3.4.2. This is a metadata/version update and does not reflect a substantive change to the study details.SummaryDifference0.1%

- Check26 days agoChange DetectedThe updates appear to be minor UI/formatting changes with no core study data changed. Core study details like eligibility, endpoints, enrollment, and locations remain intact.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision: v3.4.2 was added. The previous government funding notice and Revision: v3.4.1 were removed.SummaryDifference0.2%

- Check55 days agoChange DetectedAdded a funding-status notice about government funding lapse and the NIH Clinical Center's status. Updated the page revision tag from v3.4.0 to v3.4.1.SummaryDifference0.2%

Stay in the know with updates to Avelumab Program Rollover Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Program Rollover Study Clinical Trial page.